A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients

Publication date: Available online 8 June 2021Source: Redox BiologyAuthor(s): Cláudia M. Deus, Susana P. Pereira, Teresa Cunha-Oliveira, José Teixeira, Rui F. Simões, Fernando Cagide, Sofia Benfeito, Fernanda Borges, Nuno Raimundo, Paulo J. Oliveira
Source: Redox Biology - Category: Biology Source Type: research